Plain-English translation of NCT06293625 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether chemotherapy given before surgery—rather than after surgery—is better for older adults (age 70 and above) with advanced colon cancer. The chemotherapy being tested is called , which combines three drugs to shrink tumors before they are surgically removed. The goal is to see if this approach helps patients tolerate treatment better and have better outcomes.
Currently, older patients with advanced colon cancer often skip chemotherapy after surgery because they are too weak or frail from the operation itself. This trial is testing whether giving the medication before surgery instead might help patients stay stronger, complete their full treatment, and ultimately have better survival rates.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive three courses of chemotherapy () over about 6 weeks before your surgery. After completing the chemotherapy, you will have surgery to remove the cancer. You will visit the hospital regularly for chemotherapy infusions and blood tests to monitor your health. Your doctor will assess your overall fitness before starting to make sure you can safely receive the treatment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France